Hepatitis C Virus Infection and Mixed Cryoglobulinemia
暂无分享,去创建一个
[1] Anna Persson,et al. Preliminary study of two antiviral agents for hepatitis C genotype 1. , 2012, The New England journal of medicine.
[2] M. Zangari,et al. Novel Therapeutic Approaches to Cryoglobulinemia: Imatinib, Infliximab, Bortezomib, and Beyond , 2012 .
[3] F. Carrat,et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. , 2011, The New England journal of medicine.
[4] D. Roccatello,et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. , 2011, Autoimmunity reviews.
[5] C. Tinelli,et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. , 2011, Autoimmunity reviews.
[6] A. Zanella,et al. Rituximab therapy for autoimmune haematological diseases. , 2011, European journal of internal medicine.
[7] R. Bruno,et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. , 2011, Autoimmunity reviews.
[8] C. Rice,et al. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. , 2011, Blood.
[9] X. Bosch,et al. Life-Threatening Cryoglobulinemia , 2011 .
[10] Felicia A Tucci,et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. , 2010, Blood.
[11] D. Sène,et al. Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case–control study from a single-centre cohort of 163 patients , 2010, Gut.
[12] Felicia A Tucci,et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. , 2010, Blood.
[13] B. Cheson. Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Felicia A Tucci,et al. Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage1 , 2009, The Journal of Immunology.
[15] F. Roudot-thoraval,et al. Clinical and Morphologic Spectrum of Renal Involvement in Patients With Mixed Cryoglobulinemia Without Evidence of Hepatitis C Virus Infection , 2009, Medicine.
[16] Barbara Rehermann,et al. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.
[17] You-fu Zhu,et al. B-cell clonality in the liver of hepatitis C virus-infected patients. , 2009, World journal of gastroenterology.
[18] J. Moorman,et al. Differential regulation of SOCS‐1 signalling in B and T lymphocytes by hepatitis C virus core protein , 2008, Immunology.
[19] Felicia A Tucci,et al. Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. , 2008, Blood.
[20] C. Alpers,et al. Cryoglobulinemia and renal disease , 2008, Current opinion in nephrology and hypertension.
[21] D. Landau,et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. , 2008, Arthritis and rheumatism.
[22] C. Rice,et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. , 2008, Blood.
[23] D. Sansonno,et al. Double‐filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia , 2008, Journal of clinical apheresis.
[24] A. Stevens,et al. Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario. , 2007, Cancer treatment reviews.
[25] C. Rice,et al. Flying under the radar: the immunobiology of hepatitis C. , 2007, Annual review of immunology.
[26] Felicia A Tucci,et al. Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia , 2006, Clinical and experimental immunology.
[27] D. Sansonno,et al. Hepatitis C virus infection, cryoglobulinaemia, and beyond. , 2006, Rheumatology.
[28] A. Amoroso,et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] I. Sanz,et al. B cell depletion therapy in autoimmune diseases. , 2007, Frontiers in bioscience : a journal and virtual library.
[30] J. Yagüe,et al. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. , 2006, Seminars in arthritis and rheumatism.
[31] Y. Shoenfeld,et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. , 2006, Journal of autoimmunity.
[32] T. Asselah,et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C , 2006, Hepatology.
[33] Felicia A Tucci,et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations , 2006, Leukemia.
[34] Brent L Wood,et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. , 2006, Gastroenterology.
[35] Felicia A Tucci,et al. Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus‐infected patients with and without mixed cryoglobulinaemia , 2006, Clinical and experimental immunology.
[36] T. Asselah,et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. , 2005, Arthritis and rheumatism.
[37] B. Fessler,et al. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. , 2005, The Journal of rheumatology.
[38] D. de Jong,et al. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity , 2005, The Journal of experimental medicine.
[39] D. Sansonno,et al. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. , 2005, The Lancet. Infectious diseases.
[40] Harel Dahari,et al. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. , 2005, Journal of hepatology.
[41] J. Piette,et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. , 2005, Arthritis and rheumatism.
[42] T. Liang,et al. An in vitro model of hepatitis C virion production. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Montagnino. Reappraisal of the clinical expression of mixed cryoglobulinemia , 2005, Springer Seminars in Immunopathology.
[44] Pojen P. Chen,et al. Cross-reacting idiotypes on cryoprecipitating rheumatoid factor , 2005, Springer Seminars in Immunopathology.
[45] J. Piette,et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. , 2004, Arthritis and rheumatism.
[46] N. Waugh,et al. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. , 2004, Health technology assessment.
[47] E. Herrmann,et al. Mutations in the putative HCV‐E2 CD81 binding regions and correlation with cell surface CD81 expression , 2004, Journal of viral hepatitis.
[48] Claudio Michelassi,et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. , 2004, Seminars in arthritis and rheumatism.
[49] L. Seeff,et al. Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .
[50] U. V. von Andrian,et al. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.
[51] Felicia A Tucci,et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection , 2004, European journal of immunology.
[52] J. Renversez,et al. The kidney in mixed cryoglobulinemias , 2004, Springer Seminars in Immunopathology.
[53] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[54] D. Yeshurun,et al. Antiviral Treatment Down-Regulates Peripheral B-Cell CD81 Expression and CD5 Expansion in Chronic Hepatitis C Virus Infection , 2003, Journal of Virology.
[55] D. Sansonno,et al. Non‐enveloped HCV core protein as constitutive antigen of cold‐precipitable immune complexes in type II mixed cryoglobulinaemia , 2003, Clinical and experimental immunology.
[56] J. Tschopp,et al. BAFF and the regulation of B cell survival. , 2003, Immunology letters.
[57] R. Fanin,et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. , 2003, Blood.
[58] Felicia A Tucci,et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. , 2003, Blood.
[59] D. Doherty,et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. , 2003, Journal of hepatology.
[60] R. Dwek,et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[61] Ralf Bartenschlager,et al. Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture , 2003, Journal of Virology.
[62] H. Agut,et al. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. , 2003, Blood.
[63] J. Hoofnagle. Course and outcome of hepatitis C , 2002 .
[64] J. Hoofnagle. Course and outcome of hepatitis C , 2002, Hepatology.
[65] R. Cortese,et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus , 2002, The EMBO journal.
[66] John P. Johnson,et al. The Clinical and Morphologic Spectrum of Renal Cryoglobulinemia , 2002, Medicine.
[67] M. Newkirk. Rheumatoid factors: host resistance or autoimmunity? , 2002, Clinical immunology.
[68] G. Melli,et al. Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients , 2002, Journal of the peripheral nervous system : JPNS.
[69] S. Rosenberg. Recent advances in the molecular biology of hepatitis C virus. , 2001, Journal of molecular biology.
[70] Felicia A Tucci,et al. Molecular Characterization of B Cell Clonal Expansions in the Liver of Chronically Hepatitis C Virus-Infected Patients1 , 2001, The Journal of Immunology.
[71] Felicia A Tucci,et al. The cryoglobulins: an overview , 2001, European journal of clinical investigation.
[72] D. Stump,et al. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. , 2001, RNA.
[73] William M. Lee,et al. Efficacy and safety of pegylated (40‐kd) interferon α‐2a compared with interferon α‐2a in noncirrhotic patients with chronic hepatitis C , 2001 .
[74] S. Waggoner,et al. Hepatitis C virus: immunosuppression by complement regulatory pathway. , 2001, Viral immunology.
[75] T. Braciale,et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. , 2000, The Journal of clinical investigation.
[76] A. Carbone,et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. , 2000, Blood.
[77] Samir K. Gupta,et al. Pegylated interferon‐α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data , 2000 .
[78] M. Houghton,et al. Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding , 2000, Journal of virology.
[79] R. Bende,et al. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. , 2000, Blood.
[80] E. Johnsson,et al. Human complement regulators: a major target for pathogenic microorganisms. , 2000, Current opinion in immunology.
[81] D. Sansonno,et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.
[82] V. Agnello,et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[83] G. D'Amico,et al. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. , 1998, Kidney international.
[84] D. Sansonno,et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. , 1998, Journal of immunology.
[85] H. Müller-Hermelink,et al. Immunoglobulin VH genes of high-grade mucosa-associated lymphoid tissue lymphomas show a high load of somatic mutations and evidence of antigen-dependent affinity maturation. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[86] R. Scorza,et al. Central nervous system involvement in patients with HCV-related cryoglobulinemia. , 1998, The American journal of the medical sciences.
[87] M. Baggiolini,et al. B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.
[88] M. Trendelenburg,et al. Cryoglobulins are not essential , 1998, Annals of the rheumatic diseases.
[89] D. Sansonno,et al. Hepatitis C virus‐related proteins in kidney tissue from hepatitis C virus‐infected patients with cryoglobulinemic membranoproliferative glomerulonephritis , 1997, Hepatology.
[90] D. Sansonno,et al. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection , 1996, European journal of clinical investigation.
[91] N. Kato,et al. A novel sequence found at the 3' terminus of hepatitis C virus genome. , 1995, Biochemical and biophysical research communications.
[92] V. Agnello. The Aetiology of Mixed Cryoglobulinaemia Associated with Hepatitis C Virus Infection , 1995, Scandinavian journal of immunology.
[93] G. D'Amico,et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. , 1995, Kidney international.
[94] K. Ishak,et al. Chronic hepatitis: morphology and nomenclature. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[95] D. Hochstrasser,et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. , 1994, Journal of immunological methods.
[96] J. Pawlotsky,et al. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy , 1993, Annals of neurology.
[97] P. Marcellin,et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study , 1993, Hepatology.
[98] R. Carbone,et al. Hepatitis C virus infection and mixed cryoglobulinemia: a striking association , 1993, International journal of clinical & laboratory research.
[99] R. Chung,et al. A role for hepatitis C virus infection in type II cryoglobulinemia. , 1992, The New England journal of medicine.
[100] D. Sansonno,et al. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia , 1992, Clinical and experimental immunology.
[101] A. Denman,et al. Cryoglobulins and the immunopathological manifestations of autoimmune disease , 1992, Clinical and experimental immunology.
[102] G. Pasero,et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. , 2010, Arthritis and rheumatism.
[103] B. Frangione,et al. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. , 1991, Seminars in hematology.
[104] P. Barr,et al. Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] L. Bonomo,et al. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. , 1987, The American journal of medicine.
[106] J. Clauvel,et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.
[107] J. Wells,et al. Chemical analyses of cryoglobulins. , 1974, Immunochemistry.
[108] M. Meltzer,et al. Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. , 1966, The American journal of medicine.
[109] A. Lerner,et al. STUDIES OF CRYOGLOBULINS. I. UNUSUAL PURPURA ASSOCIATED WITH THE PRESENCE OF A HIGH CONCENTRATION OF CRYOGLOBULIN (COLD PRECIPITABLE SERUM GLOBULIN) , 1947, The American journal of the medical sciences.